Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Reset Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Reset Therapeutics

Reset Therapeutics

Series B

Biopharmaceutical firm, Reset Therapeutics, innovates modulation therapies for the human circadian system.

HQ
South San Francisco, CA, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Reset Therapeutics, founded with a mission to revolutionize biopharmaceutical treatments, focuses on developing and commercializing therapies that modulate the human circadian system. Their innovative products aim to address various health conditions by targeting the body's internal clock, offering potential solutions for disorders related to sleep, metabolism, and other circadian rhythm-related issues.

Notable figures in the company include leading scientists and industry experts dedicated to advancing circadian modulation therapies. Reset Therapeutics has garnered attention from prominent investors in the biotech sector, reflecting confidence in their groundbreaking approach. Their achievements in preclinical and clinical trials underscore their impact on the biopharmaceutical landscape, positioning them as pioneers in circadian system modulation.

Reset Therapeutics - Similar Companies

Reset Pharmaceuticals logo

Reset Pharmaceuticals

Synchronicity Pharma logo

Synchronicity Pharma

Faze Medicines logo

Faze Medicines

fazemed.com

Retro Biosciences logo

Retro Biosciences

retro.bio

Fuse Biotherapeutics logo

Fuse Biotherapeutics

fusebiotx.com

Thesan Pharmaceuticals logo

Thesan Pharmaceuticals

thesanpharma.com

Rectify Pharmaceuticals logo

Rectify Pharmaceuticals

rectifypharma.com

Reservoir Neuroscience logo

Reservoir Neuroscience

reservoirneuro.com

Eikon Therapeutics logo

Eikon Therapeutics

eikontx.com

Epic-Bio logo

Epic-Bio

epic-bio.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Remix Therapeutics logo

Remix Therapeutics

Celsius Therapeutics logo

Celsius Therapeutics

celsiustx.com

Akttyva Therapeutics logo

Akttyva Therapeutics

akttyva.com

Nested Therapeutics logo

Nested Therapeutics

nestedtx.com

Reset Therapeutics - Quick Facts

Who are Reset Therapeutics' competitors?

Companies similar to Reset Therapeutics include Reset Pharmaceuticals, Synchronicity Pharma, Faze Medicines and Retro Biosciences.

When was Reset Therapeutics founded?

Reset Therapeutics was founded in 2008.

Where is Reset Therapeutics' headquarters located?

Reset Therapeutics' headquarters is located in South San Francisco, CA, US.

When was Reset Therapeutics' last funding round?

Reset Therapeutics' most recent funding round was for $29.7M (USD) in February 2016.

How much has Reset Therapeutics raised to-date?

As of Feb 19, 2016, Reset Therapeutics has raised a total of $53.6M (USD).

How many employees does Reset Therapeutics have?

Reset Therapeutics has 30 employees as of Feb 4, 2024.

Reset Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified